Back
Zai Lab Ltd (ZLAB) Price
ZLAB Stock Price Chart
ZLAB Earnings
Zai Lab Ltd
$18.58
-1.27%
$-0.24
At close: Jan 16, 16:00:00 GMT-5
$18.58
0%
$0
Pre-market: Jan 20, 05:01:45 GMT-5
Latest Earnings Results: Q3 '25
Reported: 2025-11-06
Historical Earnings
Quarterly
Annual
EPS
Revenue
Earnings FAQ
How did ZLAB's recent EPS compare to expectations?
How did Zai Lab Ltd ZLAB's revenue perform in the last quarter?
What is the revenue estimate for Zai Lab Ltd?
What's the earning quality score for Zai Lab Ltd?
When does Zai Lab Ltd report earnings?
What are Zai Lab Ltd's expected earnings?
Did Zai Lab Ltd beat earnings expectations?
Key Stats
Prev.Close
$18.82
Open
$18.67
Day's Range
$18.42 - $18.86
52 week range
$16.82 - $44.34
Volume
516.0K
Avg.Volume
893.1K
EPS (TTM)
-1.90
Dividend yield
--
Market Cap
$2.0B
What is ZLAB?
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-09-28. The firm is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The firm has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
Features
Trading Strategies
Resources
© 2025 Finture Development Limited. All rights reserved